Two of the biggest trials were recently completed for the use of IL-17 inhibitors for treating hidradenitis suppurativa (HS). So what data should we know about? In this episode, Dr. Raj Chovatiya is joined by Dr. Martina Porter, Dermatologist at Beth Israel Deaconess Medical Center and Assistant Professor of Dermatology at Harvard Medical School.